Aldara News
Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 ... - PR Newswire (press release)
Small molecule ligands for this receptor have been identified, including topical imiquimod (Aldara(R)) which is approved for the treatment of basal cell ...
Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 ... - PharmaLive.com (press release)
Small molecule ligands for this receptor have been identified, including topical imiquimod (Aldara(R)) which is approved for the treatment of basal cell ...
Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 ... - PR Newswire (press release)
Small molecule ligands for this receptor have been identified, including topical imiquimod (Aldara(R)) which is approved for the treatment of basal cell ...
Graceway Pharma Buys Estrasorb - Private Equity Hub
Current prescription products marketed by Graceway include Aldara(R) (imiquimod) Cream 5%, Maxair(R) Autohaler(R) (pirbuterol acetate inhalation aerosol), ...
Amendment 4 to Form S-1 - Sydney Morning Herald
... of light therapy to activate the drug in the topical solution, and various topical agents such as Efudex, Solaraze, Carac, Fluoroplex and Aldara. ...
Idera Signs $421M Deal For TLR9 Cancer Agonists - BioWorld Online
Just one TLR drug has made it to market - Graceway Pharmaceuticals LLC markets the TLR7 drug Aldara (imiquimod) for superficial basal cell carcinomas, ...
Bradley Pharmaceuticals Inc announces launch of Veregen ... - Trading Markets (press release)
Current treatment for this condition primarily consists of cryosurgery and the topical therapy Aldara (imiquimod). The company's divisions Doak ...
International Stock Targets: Begins Preliminary Research on ... - Trading Markets (press release)
Current treatment for this condition primarily consists of cryosurgery and the topical therapy Aldara (imiquimod). Both the Doak Dermatologics and Kenwood ...
Efficacy of Aldara® (Imiquimod) for Treatment of Low-Risk Nodular ... - Cancer Consultants (press release)
Researchers from Germany have reported that Aldara® can eradicate 64% of low-risk nodular basal cell carcinomas. The details of this study were reported in ...
Meda AB (publ.) January – September 2007, Interim Report - Business Wire (press release)
The product portfolio acquired from 3M accounted for SEK 1565.7 million of the increase, and sales of its main products Tambocor, Minitran, and Aldara rose ...
Aldara RSS Feed